Specific primer for rapidly screening EGFR gene exon 18-21 mutation and its application
An exon-specific technology, applied in the field of genetic engineering, can solve the problems of drug resistance induced by gefitinib and erlotinib, and achieve the effect of simple and fast operation, low detection cost and fast speed
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] An in vitro detection method for rapid screening of EGFR gene exon 18-21 mutation, comprising the following steps:
[0030] (1) Extraction of Dried Blood Spot DNA
[0031] The total DNA extraction was carried out according to the instructions of the Magnetic Bead Method Dried Blood Spot Genomic DNA Extraction Kit (Tiangen), as follows:
[0032] 1. Take a new 96-well deep-well plate, and add three 3*3mm dried blood spot samples to each well. Add 200 µL of buffer GA to a 96 deep-well plate.
[0033] 2. Add 20 μL of proteinase K solution, vortex for 10 seconds to mix well, put it into a constant temperature oscillator preheated to 56 degrees, and lyse at 900 rpm for 30 minutes.
[0034] 3. During the sample lysis in the previous step, add 10 μL magnetic bead suspension G, 200 μL buffer GB and 200 μL absolute ethanol to a new 96-well deep-well plate, and mix by whipping or shaking for 10 seconds.
[0035] 4. After the sample is lysed, briefly centrifuge the deep-well pla...
Embodiment 2
[0055] Embodiment 2: clinical sample detection
[0056] The method of Example 1 was used to detect exons 18-21 of the EGFR gene in the blood of multiple cases of physical examination populations, and the detection results were as follows:
[0057] Exons 18, 19, 20, and 21 of the EGFR gene in the blood of 81 cases of colorectal cancer, 69 cases of lung cancer, 79 cases of liver cancer, 100 cases of breast cancer, and 45 cases of esophageal cancer were detected, and 19 cases of colorectal cancer were successfully detected. Cancer patients, 18 lung cancer subjects, 6 liver cancer patients, 24 breast cancer patients, and 8 esophageal cancer patients had mutations in the EGFR gene in blood DNA, and then the PCR product was detected by next-generation sequencing and compared with the human genome sequence. After comparison, it was confirmed that these 75 samples did have changes in DNA sequences.
[0058] Blood samples from 81 patients with colorectal cancer, of which 19 cases (No....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap